[1]王岳胜a,刘晓晨b,刘恩香b,等.持续性心房颤动患者血清miR-133a-3p和miR-324-3p表达与射频消融术后房颤复发的关系[J].现代检验医学杂志,2024,39(06):108-112+118.[doi:10.3969/j.issn.1671-7414.2024.06.018]
　WANG Yueshenga,LIU Xiaochenb,LIU Enxiangb,et al.Relationship between the Expressions of Serum miR-133a-3p and miR-324- 3p in Patients with Persistent Atrial Fibrillation and the Recurrence of Atrial Fibrillation after Radiofrequency Ablation[J].Journal of Modern Laboratory Medicine,2024,39(06):108-112+118.[doi:10.3969/j.issn.1671-7414.2024.06.018]
点击复制

持续性心房颤动患者血清miR-133a-3p和miR-324-3p表达与射频消融术后房颤复发的关系()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第39卷
期数:
2024年06期
页码:
108-112+118
栏目:
论著
出版日期:
2024-11-15

文章信息/Info

Title:
Relationship between the Expressions of Serum miR-133a-3p and miR-324- 3p in Patients with Persistent Atrial Fibrillation and the Recurrence of Atrial Fibrillation after Radiofrequency Ablation
文章编号:
1671-7414（2024）06-108-06
作者:
王岳胜a; 刘晓晨b; 刘恩香b; 李晶晶b
（沧州市人民医院a. 心内科；b. 心脏中心，河北沧州061000）
Author(s):
WANG Yueshenga;  LIU Xiaochenb;  LIU Enxiangb;  LI Jingjingb
（a. Department of Cardiology; b. Heart Center, Cangzhou People’s Hospital, Hebei Cangzhou 061000, China）
关键词:
持续性心房颤动; 微小RNA-133a-3p; 微小RNA-324-3p; 射频消融术; 房颤复发
分类号:
R541.75；R392.11
DOI:
10.3969/j.issn.1671-7414.2024.06.018
文献标志码:
A
摘要:
目的 探讨血清miR-133a-3p、miR-324-3p 在持续性心房颤动患者血清中的表达以及与射频消融术后房颤复发的关系。方法 收集2019 年7 月~2022 年7 月于沧州市人民医院住院诊治并接受射频消融术治疗的180 例持续性心房颤动患者（持续性心房颤动组）作为研究对象，根据房颤是否复发，分为无复发组（n=116）和复发组（n=64），另选取同期在该院体检的180 例健康人作为对照组。比较各组血清miR-133a-3p，miR-324-3p 表达水平；多因素Logistic 回归分析持续性心房颤动患者射频消融术后房颤复发的影响因素；ROC 曲线分析血清miR-133a-3p，miR-324-3p 水平对持续性心房颤动患者射频消融术后房颤复发的预测价值。结果 持续性心房颤动组血清miR-133a-3p（0.76±0.25），miR-324-3p（0.68±0.21）水平显著低于对照组（1.03±0.32，1.05±0.30），差异具有统计学意义（t=8.921，13.556，均P<0.05）。复发组血清miR-133a-3p（0.58±0.19），miR-324-3p 水平（0.50±0.16）均显著低于无复发组（0.86±0.27，0.78±0.25），差异具有统计学意义（t=7.349，8.087，均P<0.055）。多因素Logistic 回归分析，结果显示，血清miR-133a-3p[OR（95%CI）：0.673（0.534~0.848）]，miR-324-3p[OR（95%CI）：0.756 （0.629~0.909）] 为持续性心房颤动患者射频消融术后房颤复发的保护因素（均P ＜ 0.05），心率[OR（95%CI）：2.143（1.265~3.631）]、LAD[OR（95%CI）：1.756（1.159~2.661）] 为持续性心房颤动患者射频消融术后房颤复发的独立危险因素（均P<0.05）。miR-133a-3p，miR-324-3p 二者联合预测持续性心房颤动患者射频消融术后房颤复发的AUC 为0.901，敏感度和特异度分别为82.81%，86.21%，优于各自单独预测（Z=4.210，2.804，均P<0.05）。结论 持续性心房颤动患者血清miR-133a-3p，miR-324-3p 表达显著降低，二者联合对预测持续性心房颤动患者射频消融术后房颤复发有较好的参考价值。
Abstract:
Objective To investigate the expression of serum miR-133a-3p and miR-324-3p in patients with persistent atrial fibrillation and their relationship with recurrence of atrial fibrillation after radiofrequency ablation. Methods A total of 180 patients with persistent atrial fibrillation (persistent atrial fibrillation group) who were hospitalized in Cangzhou City People’s Hospital from July 2019 to July 2022 and received radiofrequency ablation were collected as research objects. According to whether atrial fibrillation recurred, they were assigned into a non recurrence group (n=116) and a recurrence group (n=64). Meanwhile, another 180 healthy individuals who underwent physical examination at the hospital were regarded as the control group. The expression levels of serum miR-133a-3p and miR-324-3p of each group were compared. Multivariate Logistic regression was applied to analyze the factors influencing the recurrence of persistent atrial fibrillation after radiofrequency ablation, and ROC curve analysis was applied to analyze the predictive value of serum miR-133a-3p and miR-324-3p levels for the recurrence of atrial fibrillation in patients with persistent atrial fibrillation after radiofrequency ablation. Results Compared with the control group, the levels of serum miR-133a-3p (0.76±0.25) and miR-324-3p (0.68±0.21) in the persistent atrial fibrillation group were lower than the control group (1.03±0.32, 1.05±0.30), and the differences were statistically significant (t=8.921, 13.556, all P<0.05). The serum levels of miR-133a-3p(0.58±0.19) and miR-324-3p (0.50±0.16) in the recurrent group were obviously lower than those in the non recurrent group (0.86±0.27, 0.78±0.25), and the differences were statistically significant (t=7.349, 8.087, all P<0.05). Multivariate Logistic regression analysis showed that serum miR-133a-3p [OR(95%CI):0.673(0.534~0.848)] and miR-324-3p [OR(95%CI): 0.756(0.629~0.909)] were protective factors for atrial fibrillation recurrence after radiofrequency ablation in patients with persistent atrial fibrillation, while heart rate [OR(95%CI): 2.143(1.265~3.631)] and LAD [OR(95%CI): 1.756(1.159~2.661)] were independent risk factors for atrial fibrillation recurrence after radiofrequency ablation in patients with persistent atrial fibrillation (all P<0.05). The AUC of the combination of miR-133a-3p and miR-324-3p in predicting atrial fibrillation recurrence after radiofrequency ablation in patients with persistent atrial fibrillation was 0.901, with the sensitivity and specificity were 82.81% and 86.21%, respectively, which was better than those of their respective prediction alone (Z=4.210, 2.804, all P<0.05). Conclusion The expressions of serum miR-133a-3p and miR-324-3p in patients with persistent atrial fibrillation are reduced, and the combination of the two has a good reference value in predicting the recurrence of atrial fibrillation in patients with persistent atrial fibrillation after radiofrequency ablation.

参考文献/References:

[1] IFEDILI I, MOUKSIAN K, JONES D, et al. Ablation therapy for persistent atrial fibrillation[J]. Current Cardiology Reviews, 2022, 18(2): e290721195115.
[2] YU H T, KIM I S, KIM T H, et al. Persistent atrial fibrillation over 3 years is associated with higher recurrence after catheter ablation[J]. Journal of Cardiovascular Electrophysiology, 2020, 31(2): 457-464.
[3] KUCK K H, LEBEDEV D S, MIKHAYLOV E N,et al. Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST) [J]. Europace, 2021, 23(3): 362-369.
[4] MARROUCHE N F, WAZNI O, MCGANN C, et al. Effect of MRI-guided fibrosis ablation vs conventional catheter ablation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the DECAAF II randomized clinical trial[J]. Journal of the American Medical Association, 2022, 327(23): 2296-2305.
[5] 张立洁, 彭泉. 基于GEO 数据库筛选慢性胰腺炎恶变过程中关键miRNA 和ceRNA 网络构建[J]. 现代检验医学杂志, 2023, 38(2) : 18-24. ZHANG Lijie, PENG Quan. Screening of key miRNAs and construction of competing endogenous RNA network involved in the progression from chronic pancreatitis to pancreatic cancer based on GEO database[J]. Journal of Modern Laboratory Medicine, 2023, 38(2): 18-24.
[6] LI Qing, WANG Yueming, HE Jingdong. MiR-133a-3p attenuates resistance of non-small cell lung cancer cells to gefitinib by targeting SPAG5[J]. Journal of Clinical Laboratory Analysis, 2021, 35(7): e23853.
[7] ZHU Wenwu, SUN Ling, ZHAO Pengcheng, et al. Macrophage migration inhibitory factor facilitates the therapeutic efficacy of mesenchymal stem cells derived exosomes in acute myocardial infarction through upregulating miR-133a-3p[J]. Journal of Nanobiotechnology, 2021, 19(1): 61.
[8] LI Fengjie, LIANG Zhen, JIA Yongqin, et al. MicroRNA-324-3p suppresses the aggressive ovarian cancer by targeting WNK2/RAS pathway[J]. Bioengineered, 2022, 13(5): 12030-12044.
[9] 张路遥, 董淑娟, 李静超, 等. 3C4L 射频消融策略治疗持续性心房颤动患者的有效性及安全性分析[J]. 临床心血管病杂志, 2022, 38(4) : 331-336. ZHANG Luyao, DONG Shujuan, LI Jingchao, et al. Efficacy and safety of “3C4L” radiofrequency ablation strategy in patients with persistent atrial fibrillation[J]. Journal of Clinical Cardiology, 2022, 38(4): 331-336.
[10] 陈灏珠, 钟南山, 陆再英. 内科学[M]. 9 版. 北京:人民卫生出版社, 2018. CHEN Haozhu, ZHONG Nanshan, LU Zaiying. Internal medicine[M]. 9th Ed.Beijing: People’s Medical Publishing House, 2018.
[11] 李晶晶, 刘晓晨, 刘恩香, 等. 心房颤动患者血清miR-29b 和miR-135b 水平表达与心房纤维化程度及射频消融术后复发的相关性研究[J]. 现代检验医学杂志, 2023, 38(6) : 75-80. LI Jingjing, LIU Xiaochen, LIU Enxiang, et al. Correlation between the expression of miR-29b and miR-135b in serum of patients with atrial fibrillation and the degree of atrial fibrosis and the recurrence after radiofrequency ablation[J]. Journal of Modern Laboratory Medicine, 2023, 38(6): 75-80.
[12] LEE J M, SHIM J, PARK J, et al. The electrical isolation of the left atrial posterior wall in catheter ablation of persistent atrial fibrillation[J]. JACC Clinical Electrophysiology, 2019, 5(11): 1253-1261.
[13] TANG Shumei, XIAO Gong, YUAN Qiongjing, et al. Long non-coding RNA ENST00000453774.1 confers an inhibitory effect on renal fibrosis by inhibiting miR-324-3p to promote NRG1 expression[J]. Frontiers in Cell and Developmental Biology, 2021, 9: 580754.
[14] LI Mengyang, DING Wei, TARIQ M A, et al. A circular transcript of ncx1 gene mediates ischemic myocardial injury by targeting miR-133a-3p[J]. Theranostics, 2018, 8(21): 5855-5869.
[15] GUO Hui, WANG Ying, JIA Wenxin, et al. MiR-133a-3p relieves the oxidative stress induced trophoblast cell apoptosis through the BACH1/Nrf2/HO-1 signaling pathway[J]. Physiological Research, 2021, 70(1): 67-78.
[16] HIRMAN A R, DU Lili, CHENG Shaohang, et al. MiR-133a-3p inhibits scar formation in scalded mice and suppresses the proliferation and migration of scar derivedfibroblasts by targeting connective tissue growth factor[J]. Experimental Animals, 2021, 70(3): 322-332.
[17] YAO Lixia, ZHOU Bolun, YOU Ling, et al. LncRNA MIAT/miR-133a-3p axis regulates atrial fibrillation and atrial fibrillation-induced myocardial fibrosis[J]. Molecular Biology Reports, 2020, 47(4): 2605-2617.
[18] ZHU Yifan, WANG Rui, CHEN Wen, et al. MiR-133a-3p attenuates cardiomyocyte hypertrophy through inhibiting pyroptosis activation by targeting IKKε[J]. Acta Histochemica, 2021, 123(1): 151653.
[19] WENG Yiping, DUAN Weihao, YU Xuecheng, et al. MicroRNA-324-3p inhibits osteosarcoma progression by suppressing PGAM1-mediated aerobic glycolysis[J]. Cancer Science, 2023, 114(6): 2345-2359.
[20] HOU Yifeng, CAI Shuang, YU Shouyang, et al. Metformin induces ferroptosis by targeting miR-324-3p/GPX4 axis in breast cancer[J]. Acta Biochimica et Biophysica Sinica, 2021, 53(3): 333-341.
[21] LIU Tingjun, TONG Jing, SHAO Chen, et al. MicroRNA-324-3p plays a protective role against coxsackievirus B3-induced viral myocarditis[J]. Virologica Sinica, 2021, 36(6): 1585-1599.
[22] XU Jiali, LEI Sisi, SUN Shuo, et al. MiR-324-3p regulates fibroblast proliferation via targeting TGF-β1 in atrial fibrillation[J]. International Heart Journal,2020, 61(6): 1270-1278.

相似文献/References:

[1]张 群,刘 婕,谢艳飞.寻常性银屑病患者血清miR-133a-3p 和PTPN22 水平表达与疾病严重程度的相关性分析[J].现代检验医学杂志,2024,39(02):135.[doi:10.3969/j.issn.1671-7414.2024.02.025]
　ZHANG Qun,LIU Jie,XIE Yanfei.Correlation Analysis between Serum miR-133a-3p and PTPN22 Levels Expression and Disease Severity in Patients with Psoriasis Vulgaris[J].Journal of Modern Laboratory Medicine,2024,39(06):135.[doi:10.3969/j.issn.1671-7414.2024.02.025]

备注/Memo

备注/Memo:
基金项目：河北省卫生健康委科研基金项目（20200292）。
作者简介： 王岳胜（1983-），男，本科，主治医师，研究方向：房颤，E-mail：wz561f@163.com。
更新日期/Last Update: 2024-11-15